Description: Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning and sunscreen products. Skinvisible, Inc. also licenses its products to manufacturers and marketers of brands internationally, as well as sells directly in the market; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was founded in 1998 and is based in Las Vegas, Nevada.
Home Page: www.skinvisible.com
6320 South Sandhill Road
Las Vegas,
NV
89120
United States
Phone:
702 433 7154
Officers
| Name | Title |
|---|---|
| Mr. Terry H. Howlett | Pres, CEO, CFO, Principal Accounting Officer & Director |
| Ms. Doreen McMorran | Head of Bus. Devel. |
| Dr. Geert Cauwenbergh Dr., Med.Sc., Ph.D. | Head of International Advisory Board |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Consumer Staples |
|---|---|
| GIC Group: | Household & Personal Products |
| GIC Industry: | Personal Products |
| GIC Sub-Industry: | Personal Products |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.3779 |
| IPO Date: | 1999-01-07 |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |